Farrell Simon
Chief Commercial Officer; Director · 2 filings · Latest: Jul 22, 2026
Serina Therapeutics, Inc.
Trevi Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TRVI | Simon Farrell | — | Mar 10, 2025 | Proposed Sale | $6.75 | 81,313 | $548.9K | — |